Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Deprescribing opioids in chronic non-cancer pain : systematic review of randomised trials

Tools
- Tools
+ Tools

Mathieson, Stephanie, Maher, Christopher G., Ferreira, Giovanni E., Hamilton, Melanie, Jansen, Jesse, McLachlan, Andrew J., Underwood, Martin and Chung-Wei, Christine Lin (2020) Deprescribing opioids in chronic non-cancer pain : systematic review of randomised trials. Drugs, 80 . pp. 1563-1576. doi:10.1007/s40265-020-01368-y ISSN 0012-6667.

[img]
Preview
PDF
WRAP-deprescribing-opioids-chronic-non-cancer-pain-systematic-review-randomised-trials-Underwood-2020.pdf - Accepted Version - Requires a PDF viewer.

Download (1904Kb) | Preview
Official URL: https://doi.org/10.1007/s40265-020-01368-y

Request Changes to record.

Abstract

Background
Deprescribing, the process of reducing or discontinuing unnecessary or harmful medicines is an essential part of clinical practice.

Objective
To evaluate the efficacy of interventions designed to deprescribe opioid analgesics for pain relief in patients with chronic non-cancer pain.

Methods
We searched electronic databases, including clinical trial registries, from database inception to 13th January 2020 without restrictions, and conducted citation tracking. Our systematic review included randomised controlled trials (RCTs) evaluating interventions reducing the prescription, or use of opioid analgesics in patients with chronic pain versus control. Inventions could be aimed at the patient, clinician, or both. We excluded trials enrolling patients with cancer or illicit drug use. Two authors independently screened and extracted data. Outcome follow-up timepoints were short (≤ 3 months), intermediate (> 3 but < 12 months) or long (≥ 12 months) term. Primary outcome was the reduction in opioid dose [morphine milligram equivalent (MME) mg/day]. Methodological quality was assessed using the Cochrane Risk of Bias Tool.

Results
We included ten patient-focused RCT interventions (n = 835; median 37 participants) and 2 testing clinician-focused interventions (n = 291 clinicians); none at low risk of bias. Patient-focused interventions did not reduce opioid dose in the intermediate term [e.g. dose reduction protocol, mean difference (MD) − 19.9 MME, 95% CI − 107.5 to 67.7], nor did they increase the number of participants who ceased their dose, or increase the risk of serious adverse events or adverse events. One clinician intervention of education plus decision tools versus decision tools alone reduced the number of opioid prescriptions (risk difference (RD) − 0.1, 95% CI − 0.2 to − 0.1), dose (MD − 5.3 MME, 95% CI − 6.2 to − 4.5) and use (RD − 0.1, 95% CI − 0.1 to − 0.0) in the long term.

Item Type: Journal Article
Alternative Title:
Subjects: R Medicine > RB Pathology
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Chronic pain, Chronic pain -- Treatment, Opioids -- Therapeutic use, Narcotics -- Therapeutic use, Pain -- Chemotherapy
Journal or Publication Title: Drugs
Publisher: Springer
ISSN: 0012-6667
Official Date: October 2020
Dates:
DateEvent
October 2020Published
31 July 2020Available
13 July 2020Accepted
Volume: 80
Page Range: pp. 1563-1576
DOI: 10.1007/s40265-020-01368-y
Status: Peer Reviewed
Publication Status: Published
Reuse Statement (publisher, data, author rights): This is a post-peer-review, pre-copyedit version of an article published in Drugs. The final authenticated version is available online at: http://dx.doi.org/10.1007/s40265-020-01368-y
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 20 July 2020
Date of first compliant Open Access: 31 July 2021
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDSydney Medical Schoolhttp://dx.doi.org/10.13039/501100004365
UNSPECIFIEDPublic Health CollaborationUNSPECIFIED

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us